Télécharger le supplément (250 p.) - KCE

More documents

Recommendations

Info

98 Médecine à l’acte/médecine au forfait – ANNEXES KCE Reports 85 S Class Level Information Class Levels Values aidsoc 2 1 2 Number of Observations Read 21778 Number of Observations Used 21778 Source DF Sum of Squares Mean Square F Value Pr > F Model 1 174944991.72 174944991.72 5.78 0.0162 Error 21776 659256545239 30274455.604 Corrected Total 21777 659431490231 R-Square Coeff Var Root MSE cat Mean 0.000265 431.1670 5502.223 1276.123 Source DF Type I SS Mean Square F Value Pr > F aidsoc 1 174944991.7 174944991.7 5.78 0.0162 Source DF Type III SS Mean Square F Value Pr > F aidsoc 1 174944991.7 174944991.7 5.78 0.0162 Parameter Estimate Standard Error t Value Pr > |t| Intercept 1257.353480 B 38.0934048 33.01
KCE Reports 85 S Médecine à l’acte/médecine au forfait – ANNEXES 99 Parameter Estimate Standard Error t Value Pr > |t| VPO 2 0.000000 B . . . The X'X matrix has been found to be singular, and a generalized inverse was used to solve the normal equations. Terms whose estimates are followed by the letter 'B' are not uniquely estimable. La prépension Class Level Information Class Levels Values prep 2 1 2 Number of Observations Read 21778 Number of Observations Used 21778 Source DF Sum of Squares Mean Square F Value Pr > F Model 1 3080170.3981 3080170.3981 0.10 0.7498 Error 21776 659428410060 30282348.001 Corrected Total 21777 659431490231 R-Square Coeff Var Root MSE cat Mean 0.000005 431.2232 5502.940 1276.123 Source DF Type I SS Mean Square F Value Pr > F prep 1 3080170.398 3080170.398 0.10 0.7498 Source DF Type III SS Mean Square F Value Pr > F prep 1 3080170.398 3080170.398 0.10 0.7498 Parameter Estimate Standard Error t Value Pr > |t| Intercept 1275.034733 B 37.4453642 34.05
Page 1 and 2:
Comparaison du coût et de la quali
Page 3 and 4:
Comparaison du coût et de la quali
Page 5 and 6:
KCE Reports 85 S Médecine à l’a
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
Page 13 and 14:
Page 15 and 16:
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
Page 49 and 50:
Page 51 and 52: KCE Reports 85 S Médecine à l’a
Page 101: KCE Reports 85 S Médecine à l’a
Page 113 and 114: KCE Reports 85 S Médecine à l'act
Page 153 and 154:
KCE Reports 85 S Médecine à l'act
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Page 193 and 194:
Page 195 and 196:
Page 197 and 198:
Page 199 and 200:
Page 201 and 202:
Page 203 and 204:
Page 205 and 206:
Page 207 and 208:
Page 209 and 210:
Page 211 and 212:
Page 213 and 214:
Page 215 and 216:
Page 217 and 218:
Page 219 and 220:
Page 221 and 222:
Page 223 and 224:
Page 225 and 226:
Page 227 and 228:
Page 229 and 230:
Page 231 and 232:
Page 233 and 234:
Page 235 and 236:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
This page is left intentionally bla
Page 247 and 248:
KCE reports 1. Efficacité et renta
Page 249:
74. Oxygénothérapie Hyperbare: Ra
show all

Télécharger le supplément (250 p.) - KCE

Create successful ePaper yourself

Delete template?

Save as template?